Stefan G. Tullius, MD, PhD, Named Joseph E. Murray Distinguished Chair in Transplant Surgery at Brigham and Women’s Hospital

Stefan G. Tullius, MD, PhD, chief of Transplant Surgery, has been appointed the Joseph E. Murray Distinguished Chair in Transplant Surgery at Brigham and Women’s Hospital.

Stefan G. Tullius, MD, PhD
Joseph E. Murray Distinguished Chair in Transplant Surgery
Chief, Division of Transplant Surgery, Brigham and Women’s Hospital
Director, Transplant Surgery Research Laboratory
Professor of Surgery, Harvard Medical School

Dr. Tullius is the chief of the Division of Transplant Surgery at Brigham and Women’s Hospital and a professor of surgery at Harvard Medical School. He received his medical degree from the Johann-Wolfgang Goethe University in Frankfurt, Germany; a PhD from the Charité in Berlin, Germany; and a (honorary) Master of Arts from Harvard University.  He has published over 280 peer-reviewed articles, led numerous externally funded studies, and is frequently invited to speak locally, nationally, and internationally.

His research career in transplantation immunology covers a period of more than 15 years and has greatly contributed to an improved understanding of the pathophysiology of long-term graft failure. His more recent research interests include individualized immunosuppression and the investigation of basic mechanisms of clinically relevant aspects in organ transplantation, focusing on novel routes for optimized utilization of organs for transplantation and organ preservation/perfusion. Dr. Tullius has also contributed with pioneering work in face, hand and uterus transplantation.

In addition to his clinical practice and research interests, Dr. Tullius has contributed to the international transplant community with his editorial, societal and committee activities. He is an executive editor of Transplantation, associate editor of Transplant International, and has served as associate and consulting editor of the American Journal of Transplantation. He has also served on the board of the European Society for Organ Transplantation (ESOT) and was the founding chair of the Basic Science Committee of ESOT. He has co-chaired several international meetings for The Transplantation Society (TTS), chaired several committees for the American Society of Transplantation (AST) and was the founding chair of the AST Vascular Composite Tissue Transplant Committee.

Dr. Tullius is currently a member of the National Kidney Registry (NKR) Medical Board, the Declaration of Istanbul Custodian Group (DICG), the senior treasurer of TTS and vice president of the International Society of Uterus Transplantation (ISUTx). In recognition of his contributions, Dr. Tullius has received several awards, including the Clinical Science Investigator Award of the AST, the Joseph E. Murray and Simon J. Simonian Award and the Excellence in Kidney Transplantation Award from the National Kidney Foundation.

Welcoming New Faculty – Kentaro Ikeda, DDS, MPH, FDS RCSEd

Please join us in welcoming Kentaro Ikeda, DDS, MPH, FDS RCSEd, as a new faculty member in the Department of Surgery.

Kentaro Ikeda, DDS, MPH, FDS RCSEd
Associate Surgeon, Division of Oral Medicine
Clinical Director, Division of Oral Medicine

Dr. Ikeda received a Doctor of Dental Surgery from the Tokyo Dental College in Japan. He completed an infectious diseases fellowship at the University of Medicine and Dentistry of New Jersey, followed by a special needs pediatric dentistry residency at the Kanagawa Children’s Medical Center in Yokohama, Japan. Dr. Ikeda then completed a general practice residency and an oral medicine residency at the Carolinas Medical Center. He also holds an MPH from the University of North Carolina at Chapel Hill School of Global Public Health.

Dr. Ikeda is a member of various professional organizations, including the American Academy of Oral Medicine, the American Academy of Pediatric Dentistry and the American Dental Association. He is a diplomat of the American Board of Oral Medicine and a fellow of the Faculty of Dental Surgery of the Royal College of Surgeons of Edinburgh.  

Before coming to the Brigham, Dr. Ikeda was an assistant professor of diagnostic and biological sciences/oral medicine and family medicine at the University of Colorado School of Dental Medicine. At the Brigham, he will also serve as clinical director of the Division of Oral Medicine. In this role, he will lead clinical improvement projects, advise regarding opportunities to promote clinical service, work with clinic managers to ensure adequate scheduling, develop clinic policies and practice guidelines, coordinate division clinical rounds and monitor faculty and staff compliance.

Dr. Ikeda’s clinical and research interests include diagnosis and management of oral mucosal diseases, orofacial pain and oral complications of systemic diseases and their management/treatment.

Quoc-Dien Trinh, MD, Awarded a $250K American Cancer Society/Pfizer Inc., Grant

Quoc-Dien Trinh, MD, has been awarded a $250K American Cancer Society/Pfizer Inc., grant for the study, “Understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer.”

Preliminary research has identified significant racial disparities in receipt of definitive therapy for men in Massachusetts who are diagnosed with intermediate and high-risk localized prostate cancer. The overall goal of the study is to use a comparative case study approach to identify factors, processes, programs and practices associated with receipt of definitive therapy and develop interventions to encourage appropriate care for Black men with prostate cancer.

Quoc-Dien Trinh, MD
Associate Surgeon, Division of Urology, Brigham and Women’s Hospital
Director, Ambulatory Clinical Operations, Division of Urology, Brigham and Women’s Hospital
Co-Director, Prostate Cancer Center, Dana-Farber/Brigham and Women’s Cancer Center
Associate Professor of Surgery, Harvard Medical School

Dr. Trinh is an associate professor of surgery at Harvard Medical School, director of Ambulatory Clinical Operations in the Division of Urology at Brigham and Women’s Hospital, and co-director of the Dana-Farber/Brigham and Women’s Prostate Cancer Center. He is also a core faculty member at the Center for Surgery and Public Health. Dr. Trinh’s research focuses primarily on inequity and outcomes of cancer care. His publications include over 500 peer-reviewed articles, book chapters and videos. His research has been funded by the American Society of Clinical Oncology (ASCO), the Prostate Cancer Foundation (PCF), the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), among others. Dr. Trinh received his medical degree from the Université de Montréal in Canada, where he also completed his residency training in urology.  He completed his fellowship in minimally invasive urologic oncology at the Vattikuti Urology Institute.